NDC 43975-0322-03
Tolterodine Tartrate 2 mg/1 CAPSULE, EXTENDED RELEASE
ANI Pharmaceuticals, Inc.
Available — 2-Day Shipping
NDC
43975-0322-03
Generic Name
Tolterodine Tartrate
Brand Name
Tolterodine Tartrate
Strength
2 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
ANI Pharmaceuticals, Inc.
FDA Drug Information
Indications & Usage
1. INDICATIONS AND USAGE Tolterodine tartrate extended-release capsules, USP are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see CLINICAL STUDIES (14) ] . Tolterodine tartrate extended-release capsules, USP are an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. (1)
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Tolterodine Tartrate Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
More from ANI Pharmaceuticals, Inc. →
Browse all ANI Pharmaceuticals, Inc. products available at wholesale
Other Tolterodine Tartrate NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 43975-0322-03 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).